LAUREN IUDICIANI: Open Payments
NPI 1275214173 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$539 in 14 payments from 11 companies in 2025. Trend: 2023 $98 · 2024 $485 · 2025 $539
Food & beverage: $539
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 1 | $124 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $95 |
| Grifols USA, LLC | 3 | $92 |
| Insmed, Inc. | 2 | $68 |
| Merck Sharp & Dohme LLC | 1 | $36 |
| United Therapeutics Corporation | 1 | $28 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $25 |
| ANI Pharmaceuticals, Inc. | 1 | $25 |
| AstraZeneca Pharmaceuticals LP | 1 | $17 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $16 |
Products named: EMBLAVEO, Prolastin-C Liquid, Arikayce, WINREVAIR, RELISTOR, PURIFIED CORTROPHIN GEL, FASENRA, GLASSIA.
Industry payments across AZ — which companies pay providers there.
